- ORCID iD
-
0000-0002-1264-4319
Show
Sort by
-
The effectiveness of second-and-third line biologics in perianal Crohn’s disease : a multicenter propensity score-matched study
-
- Journal Article
- A1
- open access
Gastrointestinal disease in common variable immunodeficiency disorder (CVID) : histological patterns, diagnostic clues and pitfalls for the pathologist and gastroenterologist
-
- Journal Article
- A1
- open access
Did we overreact? Insights on COVID-19 disease and vaccination in a large cohort of immune-mediated inflammatory disease patients during sequential phases of the pandemic (the BELCOMID study)
-
- Journal Article
- A1
- open access
Post-discharge outcomes of elderly patients hospitalized for inflammatory bowel disease flare complicated by Clostridioides difficile infection
-
New onset inflammatory bowel disease after initiation of anti-IL-17a treatment : a case series
-
Respiratory failure in a tofacitinib treated patient with ulcerative colitis
-
- Journal Article
- A1
- open access
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics : a multicenter observational study
-
- Journal Article
- A1
- open access
Unraveling the fatigue puzzle : insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis
-
Successful treatment of ulcerative colitis with anakinra : a case report
-
The comparative effectiveness and safety of different biologics in young (<60 years) versus elderly (≥60 years) patients with IBD : results from a real-world experience at a Belgian tertiary centre
(2024) Abstracts of the 19th Congress of ECCO Stockholm, Sweden, February 21-24, 2024. In Journal of Crohns & Colitis 18(Suppl. 1). p.i1739-i1740